Table of Contents Author Guidelines Submit a Manuscript
Dermatology Research and Practice
Volume 2016 (2016), Article ID 6462804, 4 pages
Research Article

A Comparison between the Effects of Glucantime, Topical Trichloroacetic Acid 50% plus Glucantime, and Fractional Carbon Dioxide Laser plus Glucantime on Cutaneous Leishmaniasis Lesions

1Skin Diseases and Leishmaniasis Research Center, Isfahan University of Medical Sciences, Isfahan 8187698191, Iran
2Skin and Stem Cell Research Center, Tehran University of Medical Sciences, Tehran 1937957514, Iran
3Department of Dermatology, Isfahan University of Medical Sciences, Isfahan 8174675731, Iran

Received 11 November 2015; Revised 14 March 2016; Accepted 30 March 2016

Academic Editor: Bruno A. Bernard

Copyright © 2016 Fariba Jaffary et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


Background. Cutaneous leishmaniasis is an endemic disease in Iran. Pentavalent antimonial drugs have been the first line of therapy in cutaneous leishmaniasis for many years. However, the cure rate of these agents is still not favorable. This study was carried out to compare the efficacies of intralesional glucantime with topical trichloroacetic acid 50% (TCA 50%) + glucantime and fractional carbon dioxide laser + glucantime in the treatment of cutaneous leishmaniasis. Methods. A total of 90 patients were randomly divided into three groups of 30 to be treated with intralesional injection of glucantime, a combination of topical TCA 50% and glucantime, or a combination of fractional laser and glucantime. The overall clinical improvement and changes in sizes of lesions and scars were assessed and compared among three groups. Results. The mean duration of treatment was weeks in all patients (range: 2–12 weeks) and , , and weeks in glucantime, topical TCA plus glucantime, and fractional laser plus glucantime groups, respectively (). Complete improvement was observed in 10 (38.5%), 27 (90%), and 20 (87%) patients of glucantime, glucantime + TCA, and glucantime + laser groups, respectively (). Conclusion. Compared to glucantime alone, the combination of intralesional glucantime and TCA 50% or fractional CO2 laser had significantly higher and faster cure rate in patients with cutaneous leishmaniasis.